Thomas Lindner

Thomas Lindner

Auto-generated profile, based on publicly available information

Thomas Lindner

Department for Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JYJianquan Yang
Jianquan Yang
JXJingli Xu
Jingli Xu
RGRene Gonzalez
Rene Gonzalez
TLThomas Lindner
Thomas Lindner
CKClemens Kratochwil
Clemens Kratochwil
YMYubin Miao
Yubin Miao
68 Ga-DOTA-GGNle-CycMSH hex , a radiolabeled melanocortin-1 receptor–targeting imaging probe, detects melanoma in first-in-human testing.

21 August 2021 in EJNMMI Radiopharmacy and Chemistry
Verified
Journal Article
Open access
PDF file
SNSadahiro Naka
Sadahiro Naka
TWTadashi Watabe
Tadashi Watabe
TLThomas Lindner
Thomas Lindner
JCJens Cardinale
Jens Cardinale
KKKenta Kurimoto
Kenta Kurimoto
Frederik L. GieselFrederik L. Giesel
Frederik L. Giesel
Background: Fibroblast activation protein (FAP) is overexpressed in the stroma of many types of cancer. [18F]AlF-FAPI-74 is a positron emission tomography tracer with high selectivity for FAP, which has already shown high accumulation within human tumors in clinical studies. However, [18F]AlF-FAPI-74 radiosynthesis has not been optimized using an automated synthesizer. Herein, we report a one-pot and one-step automated radiosynthesis method using a multi purpose synthesizer. Results: Radiosynthesis of [18F]AlF-FAPI-74 was performed using a cassette-type multi purpose synthesizer CFN-MPS200. After the recovery rate of trapped [18F]fluoride onto the anion-exchange cartridge using a small amount of eluent was investigated manually, a dedicated [18F]AlF-FAPI-74 synthesis cassette and synthesis program for one-pot and one-step fluorination was developed. The solutions for the formulation of [18F]AlF-FAPI-74 synthesized using this were evaluated to obtain stable radiochemical purity. The recovery rate of [18F]fluoride with only 300 µL of eluent ranged 90 ± 9% by introduction from the male side and elution from the female side of the cartridge. In automated synthesis, the eluted [18F]fluoride and precursor solution containing aluminum chloride were mixed; then, fluorination was performed in a one-pot and one-step process at room temperature for 5 min, followed by 15 min at 95 °C. As a result, the radioactivity of [18F]AlF-FAPI-74 was 11.3 ± 1.1 GBq at the end of synthesis from 32 to 40 GBq of [18F]fluoride, and its radiochemical yield was 37 ± 4% (n = 10). The radiochemical purity at the end of the synthesis was ≥ 97% for all formulation solutions. When the diluent was saline, the radiochemical purity markedly decreased after 4 h of synthesis. In contrast, with phosphate-buffered saline (pH 7.4) or 10 mM phosphate-buffered saline (pH 6.7) containing 100 mg of sodium ascorbate, the radiochemical purity was stable at 97%. Non-radioactive AlF-FAPI-74 and total impurities, including non-radioactive AlF-FAPI-74, were 0.3 ± 0.1 µg/mL and 2.8 ± 0.6 µg/mL. Ethanol concentration and residual DMSO were 5.5 ± 0.2% and 21 ± 6 ppm, respectively. Conclusions: We established a one-pot one-step automated synthesis method using a CFN-MPS200 synthesizer that provided high radioactivity and stable radiochemical purity for possible clinical applications.